Galapagos, a global biotechnology company, has appointed the founding CEO of its new subsidiary & announced the search for a ...

Smith, Head of Business Development, Douglas CDMO, touts the advantages of and dispels misconceptions about mid-sized CDMOs.

Repertoire Immune Medicines has entered into a collaboration and license agreement with Genentech to discover and develop innovative T cell-targeted immune medicines.

Singh will lead the discovery and clinical translation of peptide medicines, investing in new technologies, including data and computational science.

Antag Therapeutics, a biopharmaceutical company pioneering novel treatments for obesity, has appointed three new hires to support the Company’s next phase of growth following the recent initiation of ...